Vivoryon Therapeutics NV
AEX:VVY
Vivoryon Therapeutics NV
Intangible Assets
Vivoryon Therapeutics NV
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Vivoryon Therapeutics NV
AEX:VVY
|
Intangible Assets
€865k
|
CAGR 3-Years
18%
|
CAGR 5-Years
122%
|
CAGR 10-Years
27%
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Intangible Assets
€1.6B
|
CAGR 3-Years
94%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Intangible Assets
€12.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Intangible Assets
€1.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Intangible Assets
€16.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-12%
|
|
|
Formycon AG
XETRA:FYB
|
Intangible Assets
€444.1m
|
CAGR 3-Years
749%
|
CAGR 5-Years
368%
|
CAGR 10-Years
127%
|
|
Vivoryon Therapeutics NV
Glance View
The company is headquartered in Halle, Sachsen-Anhalt and currently employs 16 full-time employees. The company went IPO on 2014-10-27.
See Also
What is Vivoryon Therapeutics NV's Intangible Assets?
Intangible Assets
865k
EUR
Based on the financial report for Dec 31, 2024, Vivoryon Therapeutics NV's Intangible Assets amounts to 865k EUR.
What is Vivoryon Therapeutics NV's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
27%
Over the last year, the Intangible Assets growth was -8%. The average annual Intangible Assets growth rates for Vivoryon Therapeutics NV have been 18% over the past three years , 122% over the past five years , and 27% over the past ten years .